- Country: Ukraine
- Summary: Dk 021:2015 - 33600000-6 - Pharmaceutical Products Xelyanz (Inn: Tofacitinib or Equivalent) Oktra (Inn: Octreotide or Equivalent)
- UAT Ref No: 101725458
- Deadline: 03 Jun 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 263346.96
- Notice Type: Tender
- Document Ref. No.: UA-2024-05-24-010201-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Prozorro identifier: UA-2024-05-24-010201-a Expected cost: UAH 263,346.96 including VAT Type of procurement subject: The main procurement subject is products, objects of any type and purpose, including raw materials, products , equipment, technologies, objects in a solid, liquid and gaseous state,
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDk 021:2015 - 33600000-6 - Pharmaceutical Products Xelyanz (Inn: Tofacitinib or Equivalent) Oktra (Inn: Octreotide or Equivalent) - Ukraine Tender
The COMMUNAL NON-COMMERCIAL ENTERPRISE CENTER OF PRIMARY MEDICAL AND SANITARY CARE 4 ODESA CITY COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Dk 021:2015 - 33600000-6 - Pharmaceutical Products Xelyanz (Inn: Tofacitinib or Equivalent) Oktra (Inn: Octreotide or Equivalent). This tender is published on UkraineTenders under UAT Ref No: 101725458 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-06-03.
The estimated tender value is UAH 263346.96, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
